181 related articles for article (PubMed ID: 8072744)
1. A comparative study of 99Tcm-HMPAO and 99Tcm-ECD as a leukocyte labelling agent.
Kao CH; Huang WT; Wang YL; Lin KS; Lo JM; Wang SJ
Nucl Med Commun; 1994 Apr; 15(4):294-7. PubMed ID: 8072744
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.
Tsai CS; Kao CH; Yeh SJ; Wang SJ
Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477
[TBL] [Abstract][Full Text] [Related]
3. 99Tcm-phenylene imine phenol as a potential leukocyte labelling agent.
Huang WT; Lo JM; Kao CH; Wang SJ
Nucl Med Commun; 1997 Jan; 18(1):66-9. PubMed ID: 9061704
[TBL] [Abstract][Full Text] [Related]
4. A high-efficiency, rapid and multi-dose procedure for white blood cell labelling with 99Tcm-HMPAO.
Ozker K; Collier BD; Hellman RS; Isitman AT; Krasnow AZ; Uzum F; Steffel FS
Nucl Med Commun; 1996 Apr; 17(4):342-5. PubMed ID: 8786871
[TBL] [Abstract][Full Text] [Related]
5. Stabilization of Tc-99m D,L-HMPAO preparations as a leucocyte labelling agent.
Kao CH; Huang WT; Tsai CS
Appl Radiat Isot; 1998 Dec; 49(12):1595-8. PubMed ID: 9745694
[TBL] [Abstract][Full Text] [Related]
6. The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oxime.
Danpure HJ; Osman S; Carroll MJ
Nucl Med Commun; 1988 Jun; 9(6):465-75. PubMed ID: 3412734
[TBL] [Abstract][Full Text] [Related]
7. A study of the behaviour of cobalt chloride during the labelling of leukocytes with 99Tcm-HMPAO stabilised in vitro by the addition of cobalt chloride solution.
Prangere T; Bowden AD; Beauchat V; Caulier MT; Ziegels P; Huglo D; Pickett RD; Steinling M
Nucl Med Commun; 1997 Mar; 18(3):258-61. PubMed ID: 9106780
[TBL] [Abstract][Full Text] [Related]
8. How to interpret differing cerebral blood flow patterns estimated with 99Tcm-HMPAO and 99Tcm-ECD SPET in a healthy population.
Siennicki-Lantz A; Lilja B; Elmståhl S
Nucl Med Commun; 1999 Mar; 20(3):219-26. PubMed ID: 10093071
[TBL] [Abstract][Full Text] [Related]
9. Imaging inflammation with 99Tcm HMPAO labelled leucocytes.
Reynolds JH; Graham D; Smith FW
Clin Radiol; 1990 Sep; 42(3):195-8. PubMed ID: 2208930
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the stability of (99m)Tc-ECD and stabilized (99m)Tc-HMPAO stored in syringes.
Koslowsky IL; Brake SE; Bitner SJ
J Nucl Med Technol; 2001 Dec; 29(4):197-200. PubMed ID: 11756532
[TBL] [Abstract][Full Text] [Related]
11. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
[TBL] [Abstract][Full Text] [Related]
12. In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.
Ecclestone M; Proulx A; Ballinger JR; Gerson B; Reid RH; Gulenchyn KY
Eur J Nucl Med; 1990; 16(4-6):299-302. PubMed ID: 2161770
[TBL] [Abstract][Full Text] [Related]
13. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
[TBL] [Abstract][Full Text] [Related]
14. A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO.
Welling M; Feitsma HI; Blok D; Calame W; Ensing GJ; Goedemans W; Pauwels EK
Q J Nucl Med; 1995 Jun; 39(2):89-98. PubMed ID: 8574810
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of white blood cell labelling with 99Tcm radiopharmaceuticals.
Segall GM; Lang EV; Chaovapong W
Nucl Med Commun; 1994 Oct; 15(10):845-9. PubMed ID: 7838449
[TBL] [Abstract][Full Text] [Related]
16. A comparison of three methods to determine the radiochemical purity of 99Tcm-hexamethylpropylene amine oxime (99Tcm-HMPAO).
Mah G; Reilly RM; Wong GL; Houle S
Nucl Med Commun; 1989 Oct; 10(10):733-40. PubMed ID: 2616098
[TBL] [Abstract][Full Text] [Related]
17. 99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes.
Peters AM; Roddie ME; Danpure HJ; Osman S; Zacharopoulos GP; George P; Stuttle AW; Lavender JP
Nucl Med Commun; 1988 Jun; 9(6):449-63. PubMed ID: 3412733
[TBL] [Abstract][Full Text] [Related]
18. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals.
Bogsrud TV; Chen MN; Herold TJ; Mahoney DW; Hung JC
Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414
[TBL] [Abstract][Full Text] [Related]
19. [Stabilization of 99m Tc-HMPAO with methylene blue: its use in leukocyte labelling)].
García Seguí V; Roca Engroñat M; Armero Muñoz F; Iglesias Allende F; Gomes Barreto de Mélo V; Martin-Comín J
Rev Esp Med Nucl; 1998; 17(4):261-4. PubMed ID: 9721341
[TBL] [Abstract][Full Text] [Related]
20. 99Tcm hexamethylpropyleneamineoxime (HMPAO) as a platelet label: evaluation of labelling parameters and first in vivo results.
Becker W; Börner W; Borst U
Nucl Med Commun; 1988 Oct; 9(10):831-42. PubMed ID: 3211441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
